Agape ATP Corp Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Agape ATP Corp on January 2, 2024, reporting events that occurred on December 28, 2023. The company is incorporated in Nevada and its common stock trades on the NASDAQ Capital Market under the symbol ATPC.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The report focuses exclusively on a change in executive compensation.
Material Changes
On December 28, 2023, the Company amended the Executive Director Agreement with Dr. How Kok Choong, who serves as Chief Executive Officer, President, Chief Operating Officer, and Executive Director. Under the original agreement dated June 1, 2016, Dr. How received $0 in annual compensation. The amendment increases his annual compensation to $400,000. All other terms of the original agreement remain in effect.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of specific risks and contingencies beyond the disclosure of the executive compensation change.
Key Facts for Investor Verification
- Dr. How Kok Choong's annual compensation increased from $0 to $400,000 effective December 28, 2023.
- The amendment was executed while Dr. How holds multiple principal officer roles (CEO, President, COO).
- The filing does not disclose the company's current financial performance or liquidity position.
- Investors should review the attached Exhibit 99.2 for the full terms of the Amendment Agreement.